Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
- PMID: 31048509
- DOI: 10.1136/thoraxjnl-2018-212996
Multidisciplinary home-based rehabilitation in inoperable lung cancer: a randomised controlled trial
Abstract
Background: Lung cancer is associated with poor health-related quality of life (HRQoL) and high symptom burden. This trial aimed to assess the efficacy of home-based rehabilitation versus usual care in inoperable lung cancer.
Methods: A parallel-group, assessor-blinded, allocation-concealed, randomised controlled trial. Eligible participants were allocated (1:1) to usual care (UC) plus 8 weeks of aerobic and resistance exercise with behaviour change strategies and symptom support (intervention group (IG)) or UC alone. Assessments occurred at baseline, 9 weeks and 6 months. The primary outcome, change in between-group 6 min walk distance (6MWD), was analysed using intention-to-treat (ITT). Subsequent analyses involved modified ITT (mITT) and included participants with at least one follow-up outcome measure. Secondary outcomes included HRQoL and symptoms.
Results: Ninety-two participants were recruited. Characteristics of participants (UC=47, IG=45): mean (SD) age 64 (12) years; men 55%; disease stage n (%) III=35 (38) and IV=48 (52); radical treatment 46%. There were no significant between-group differences for the 6MWD (n=92) at 9 weeks (p=0.308) or 6 months (p=0.979). The mITT analyses of 6MWD between-group differences were again non-significant (mean difference (95% CI): 9 weeks: -25.4 m (-64.0 to 13.3), p=0.198 and 6 months: 41.3 m (-26.7 to 109.4), p=0.232). Significant 6-month differences, favouring the IG, were found for HRQoL (Functional Assessment of Cancer Therapy-Lung: 13.0 (3.9 to 22.1), p=0.005) and symptom severity (MD Anderson Symptom Inventory-Lung Cancer: -2.2 (-3.6 to -0.9), p=0.001).
Conclusions: Home-based rehabilitation did not improve functional exercise capacity but there were improvements in patient-reported exploratory secondary outcomes measures observed at 6 months.
Trial registration: Australian New Zealand Clinical Trials Registry (ACTRN12614001268639).
Keywords: exercise; non-small cell lung cancer.
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Should pulmonary rehabilitation be a standard of care in lung cancer?Thorax. 2019 Aug;74(8):725-726. doi: 10.1136/thoraxjnl-2019-213157. Epub 2019 May 15. Thorax. 2019. PMID: 31092673 No abstract available.
-
Critically appraised paper: In people with inoperable lung cancer, home-based rehabilitation provides no benefit over usual care in optimising functional exercise capacity [commentary].J Physiother. 2020 Jan;66(1):57. doi: 10.1016/j.jphys.2019.11.009. Epub 2019 Dec 13. J Physiother. 2020. PMID: 31843421 No abstract available.
-
Critically appraised paper: In people with inoperable lung cancer, home-based rehabilitation provides no benefit over usual care in optimising functional exercise capacity [synopsis].J Physiother. 2020 Jan;66(1):57. doi: 10.1016/j.jphys.2019.11.010. Epub 2019 Dec 16. J Physiother. 2020. PMID: 31859150 No abstract available.
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical